Latest medicine updates

173 updates found

New Updated Retired

Date range

DOCUMENT TYPE

SPC

PIL

STATUS

New

Updated

Retired

	Entocort CR 3mg Capsules budesonide Updated 25-Sep-17 Document history Tillotts Pharma UK Limited		Change to section 4.1 - Therapeutic indications Change to section 10 - Date of revision of the text

	Fostair 200/6 inhalation solution beclometasone dipropionate, formoterol fumarate dihydrate Updated 25-Sep-17 Document history Chiesi Limited		Change to section 6 - date of revision Change to section 6 - manufacturer

	Gaviscon Advance Peppermint Flavour Oral Suspension sodium alginate, potassium bicarbonate Retired 25-Sep-17 Reckitt Benckiser Healthcare (UK) Ltd		Product/presentation currently not marketed

	Gaviscon Advance Mint Chewable Tablets sodium alginate, potassium bicarbonate Retired 25-Sep-17 Reckitt Benckiser Healthcare (UK) Ltd		Product/presentation currently not marketed

	Gaviscon Advance Aniseed Suspension sodium alginate, potassium bicarbonate Retired 25-Sep-17 Reckitt Benckiser Healthcare (UK) Ltd		Product/presentation currently not marketed

	Gaviscon Advance Aniseed sodium alginate, potassium hydrogen carbonate Retired 25-Sep-17 Reckitt Benckiser Healthcare (UK) Ltd		Product/presentation discontinued

	Nebido 1000mg/4ml, solution for injection testosterone undecanoate Updated 25-Sep-17 Document history Bayer plc		Change to section 6 - date of revision Change to section 6 - marketing authorisation holder

	Inhixa 2,000 IU (20 mg) in 0.2 mL solution for injection in pre-filled syringe enoxaparin sodium Updated 25-Sep-17 Document history Techdow Pharma Ltd		Improved presentation of SPC

	Inhixa 10,000 IU (100 mg) in 1.0 mL solution for injection in pre-filled syringe enoxaparin sodium Updated 25-Sep-17 Document history Techdow Pharma Ltd		Improved presentation of SPC

	Proleukin aldesleukin Updated 25-Sep-17 Document history Novartis Pharmaceuticals UK Ltd		Change to section 5 - how to store or dispose Change to section 4 - possible side effects Change to section 6 - date of revision

	Proleukin aldesleukin Updated 25-Sep-17 Document history Novartis Pharmaceuticals UK Ltd		Change to section 4.8 - Undesirable effects Change to section 5.1 - Pharmacodynamic properties Change to section 6.3 - Shelf life Change to section 6.6 - Special precautions for disposal and other handling Change to section 10 - Date of revision of the text

	Gabapentin Mylan 100 mg Capsules, Hard gabapentin Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Gabapentin Mylan 300 mg Capsules, Hard gabapentin Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Minocycline 50 mg Film-coated Tablets minocycline hydrochloride Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Minocycline 100 mg Film-coated Tablets minocycline hydrochloride Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Irbesartan/Hydrochlorothiazide 150 mg/12.5 mg, 300 mg/12.5 mg & 300 mg/25 mg Film-Coated Tablets hydrochlorothiazide, irbesartan Updated 25-Sep-17 Document history Lupin (Europe) Ltd		Change to section 5 - how to store or dispose Change to section 4 - possible side effects Change to section 2 - interactions with other medicines, food or drink Change to section 2 - pregnancy, breast feeding and fertility Change to section 3 - dose and frequency

	Nefopam Hydrochloride 30mg Film-Coated Tablets nefopam hydrochloride Updated 25-Sep-17 Galen Limited		New PIL for new product

	Terbinafine 250mg Tablets terbinafine hydrochloride Updated 25-Sep-17 Wockhardt UK Ltd		New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

	Retacrit solution for injection in pre-filled syringe epoetin zeta Updated 25-Sep-17 Document history Hospira UK Ltd		Change to section 2 - what you need to know - warnings and precautions Change to section 4 - possible side effects Change to section 6 - date of revision

	Mozobil 20 mg/ml solution for injection plerixafor Updated 25-Sep-17 Document history Genzyme Therapeutics		Correction of spelling/typing errors

	Munalea 150/30 micrograms Film-coated Tablets ethinylestradiol, desogestrel Updated 25-Sep-17 Document history Lupin (Europe) Ltd		Change to section 6.3 - Shelf life

	TENSAID XL 1.5 mg, prolonged-release film-coated tablet indapamide Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Imatinib 400 mg film-coated tablets imatinib mesilate Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Gabapentin Mylan 400 mg Capsules, Hard gabapentin Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Azithromycin 250 mg, 500 mg Film-coated Tablets azithromycin monohydrate Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Psytixol 20 mg/ml injection flupentixol decanoate Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Psytixol 100 mg/ml injection flupentixol decanoate Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Mylatrip 2.5 mg Film-coated Tablets frovatriptan succinate monohydrate Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Psytixol 200 mg/ml injection flupentixol decanoate Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Kyleena 19.5 mg intrauterine delivery system levonorgestrel Updated 25-Sep-17 Document history Bayer plc		Change to section 7 - Marketing authorisation holder Change to section 10 - Date of revision of the text

	Jaydess 13.5 mg intrauterine delivery system levonorgestrel Updated 25-Sep-17 Document history Bayer plc		Change to section 7 - Marketing authorisation holder Change to section 10 - Date of revision of the text

	Fosinopril Sodium 20 mg Tablets fosinopril sodium Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Prolia denosumab Updated 25-Sep-17 Document history Amgen Ltd		Change to section 2 - what you need to know - warnings and precautions Change to section 5 - how to store or dispose Change to section 4 - possible side effects

	ELOINE 0.02 mg / 3 mg film coated tablets ethinylestradiol, drospirenone Updated 25-Sep-17 Document history Bayer plc		Change to section 7 - Marketing authorisation holder Change to section 10 - Date of revision of the text

	Lemsip Cold & Flu Blackcurrant paracetamol, phenylephrine hydrochloride Updated 25-Sep-17 Document history Reckitt Benckiser Healthcare (UK) Ltd		Change to section 6 - what the product looks like and pack contents Change to section 2 - what you need to know - contraindications Change to section 3 - overdose, missed or forgotten doses Change to section 5 - how to store or dispose Change to section 4 - possible side effects Change to section 2 - interactions with other medicines, food or drink Change to section 2 - pregnancy, breast feeding and fertility Change to section 6 - date of revision Change to section 4 - how to report a side effect

	Fosinopril Sodium 10 mg Tablets fosinopril sodium Updated 25-Sep-17 Generics UK T/A Mylan		New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

	Ferrous Fumarate 322mg Film Coated Tablets ferrous fumarate Updated 25-Sep-17 Document history Concordia International - formerly AMCo		Change to section 6 - date of revision Change to section 6 - manufacturer

	Betmiga 25mg & 50mg prolonged-release tablets mirabegron Updated 25-Sep-17 Document history Astellas Pharma Ltd		Improved presentation of PIL Change to section 2 - what you need to know - warnings and precautions Change to section 2 - what you need to know - contraindications Change to section 3 - overdose, missed or forgotten doses Change to section 4 - possible side effects Change to section 2 - interactions with other medicines, food or drink Change to section 2 - pregnancy, breast feeding and fertility Change to section 6 - date of revision Change to section 3 - how to take/use Removal of black triangle

	Teveten 300 mg Film-coated Tablets eprosartan mesilate Updated 25-Sep-17 Document history Mylan Products Limited		Change to section 6.5 - Nature and contents of container Change to section 10 - Date of revision of the text

	Fenofibrate 267mg Capsules fenofibrate Updated 25-Sep-17 Document history Zentiva		Change to section 2 - what you need to know - warnings and precautions Change to section 3 - overdose, missed or forgotten doses Change to section 4 - possible side effects Change to section 6 - date of revision Change to section 3 - how to take/use

	Xarelto 15mg & 20mg film-coated tablets rivaroxaban Updated 25-Sep-17 Document history Bayer plc		Change to section 6 - date of revision Change to section 3 - how to take/use Change to section 4 - how to report a side effect

	Kyntheum 210 mg Solution for Injection brodalumab Updated 25-Sep-17 Document history Leo Laboratories Limited		Change to section 6.5 - Nature and contents of container Change to section 8 - Marketing authorisation number(s) Change to section 10 - Date of revision of the text

	Catapres Ampoules clonidine hydrochloride Updated 25-Sep-17 Document history Boehringer Ingelheim Limited		Change to section 6.3 - Shelf life Change to section 10 - Date of revision of the text

	Prolia denosumab Updated 25-Sep-17 Document history Amgen Ltd		Change to section 4.8 - Undesirable effects Change to section 6.6 - Special precautions for disposal and other handling

	Xarelto 20mg film-coated tablets rivaroxaban Updated 25-Sep-17 Document history Bayer plc		Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for use Change to section 5.1 - Pharmacodynamic properties Change to section 10 - Date of revision of the text

	Xarelto 15mg film-coated tablets rivaroxaban Updated 25-Sep-17 Document history Bayer plc		Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for use Change to section 5.1 - Pharmacodynamic properties Change to section 10 - Date of revision of the text

	Permethrin 5% w/w Cream permethrin Updated 25-Sep-17 Document history Sandoz Limited		Change to section 4.4 - Special warnings and precautions for use Change to section 10 - Date of revision of the text

	Clindamycin 150mg Capsules clindamycin hydrochloride Updated 25-Sep-17 Document history Sandoz Limited		Change to section 4.2 - Posology and method of administration Change to section 4.4 - Special warnings and precautions for use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.8 - Undesirable effects Change to section 6.6 - Special precautions for disposal and other handling

	Co-amoxiclav 500/125 mg Tablets clavulanic acid, amoxicillin trihydrate Updated 25-Sep-17 Document history Sandoz Limited		Change to section 4.8 - Undesirable effects Change to section 10 - Date of revision of the text

	Betmiga 25mg & 50mg prolonged-release tablets mirabegron Updated 25-Sep-17 Document history Astellas Pharma Ltd		Change to section 4.2 - Posology and method of administration Change to section 4.3 - Contraindications Change to section 4.4 - Special warnings and precautions for use Change to section 4.5 - Interaction with other medicinal products and other forms of interaction Change to section 4.6 - Fertility, pregnancy and lactation Change to section 4.8 - Undesirable effects Change to section 5.1 - Pharmacodynamic properties Change to section 5.2 - Pharmacokinetic properties Change to section 6.1 - List of excipients Change to section 6.5 - Nature and contents of container Change to section 9 - Date of first authorisation/renewal of the authorisation Change to section 10 - Date of revision of the text Removal of black triangle

Page 1 of 4 Next

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue

Find out more here.